Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Erratum to 'Hip and Knee Section, Treatment, Surgical Technique: Proceedings of International Consensus on Orthopedic Infections' [The Journal of Arthroplasty 34 (2019) S445-S451].

Abouljoud MM, Backstein D, Battenberg A, Dietz M, Erice A, Freiberg AA, Granger J, Katchky A, Khlopas A, Kim TK, Kjaersgaard-Andersen P, Koo KH, Kosashvili Y, Lazarovski P, Leighton J, Lombardi A, Malizos K, Manrique J, Mont MA, Papanagiotoy M, Sierra RJ, Sodhi N, Stammers J, Stiehler M, Tan TL, Uchiyama K, Ward D, Ziogkou A.

J Arthroplasty. 2019 Jun;34(6):1300. doi: 10.1016/j.arth.2019.02.063. Epub 2019 Mar 28. No abstract available.

PMID:
30930160
2.

Hip and Knee Section, Treatment, Surgical Technique: Proceedings of International Consensus on Orthopedic Infections.

Abouljoud MM, Backstein D, Battenberg A, Dietz M, Erice A, Freiberg AA, Granger J, Katchky A, Khlopas A, Kim TK, Kjaersgaard-Andersen P, Koo KH, Kosashvili Y, Lazarovski P, Leighton J, Lombardi A, Malizos K, Manrique J, Mont MA, Papanagiotoy M, Sierra RJ, Sodhi N, Stammers J, Stiehler M, Tan TL, Uchiyama K, Ward D, Ziogkou A.

J Arthroplasty. 2019 Feb;34(2S):S445-S451. doi: 10.1016/j.arth.2018.09.029. Epub 2018 Oct 19. No abstract available. Erratum in: J Arthroplasty. 2019 Jun;34(6):1300.

PMID:
30348548
3.

Septic arthritis following arthroscopic reconstruction of cruciate ligaments of the knee: retrospective case review.

Erice A, Neira MI, Vargas-Prada S, Chiaraviglio A, Gutiérrez-Guisado J, Rodríguez de Oya R.

Enferm Infecc Microbiol Clin. 2018 Jun - Jul;36(6):336-341. doi: 10.1016/j.eimc.2017.05.002. Epub 2017 Jun 23. English, Spanish.

PMID:
28651785
4.

Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

Weinberg A, Bosch R, Bennett K, Tovar-Salazar A, Benson CA, Collier AC, Zolopa A, Gulick RM, Wohl D, Polsky B, Erice A, Jacobson MA.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):25-32. doi: 10.1097/QAI.0000000000000095.

5.

[Prevalence of HIV infection among healthy workers].

Erice A, Chiaraviglio A.

Med Clin (Barc). 2011 Apr 16;136(10):458-9. doi: 10.1016/j.medcli.2009.07.035. Epub 2009 Oct 12. Spanish. No abstract available.

PMID:
19819493
6.

Hepatitis C virus does not infect muscle, the intervertebral disk, or the meniscus in patients with chronic hepatitis C.

Bartolomé J, Rodríguez-Iñigo E, Erice A, Vidal S, Castillo I, Carreño V.

J Med Virol. 2007 Dec;79(12):1818-20.

PMID:
17935188
7.

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB; AIDS Clinical Trials Group 328 Study Team.

Arch Intern Med. 2007 Mar 26;167(6):597-605.

PMID:
17389292
8.

Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.

Mallolas J, Arnedo M, Pumarola T, Erice A, Blanco JL, Martínez E, Gatell JM.

AIDS. 2006 Jan 9;20(2):285-7.

PMID:
16511424
9.

Occam can be wrong: a young man with lumbar pain and acute weakness of the legs.

Neira MI, Sánchez J, Moreno I, Chiaraviglio A, Rayo A, Gutiérrez J, Erice A.

Lancet. 2006 Feb 11;367(9509):540. No abstract available.

PMID:
16473136
10.

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.

Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B; AIDS Clinical Trials Group 360 Team.

J Infect Dis. 2006 Feb 15;193(4):488-93. Epub 2006 Jan 3.

PMID:
16425127
11.

Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome.

de Górgolas M, Erice A, Gil A, Gutiérrez J, Rivas P, Hernando C, Rodríguez MC.

Scand J Infect Dis. 2005;37(6-7):526-8.

PMID:
16012021
12.

Altered replicative capacity of recombinant HIV type 1 containing mutations at codons 26 and 29 of the viral protease.

Melón S, Gil-Roda C, de Oña M, Erice A.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1183-8.

PMID:
15588340
13.

HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.

Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA; AIDS Clinical Trials Group Protocol 388.

Clin Infect Dis. 2004 Aug 15;39(4):552-8. Epub 2004 Jul 30.

PMID:
15356820
14.

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.

Fischl MA, Ribaudo HJ, Collier AC, Erice A, Giuliano M, Dehlinger M, Eron JJ Jr, Saag MS, Hammer SM, Vella S, Morse GD, Feinberg JE, Demeter LM, Eshleman SH; Adult AIDS Clinical Trials Group 388 Study Team.

J Infect Dis. 2003 Sep 1;188(5):625-34. Epub 2003 Aug 15. Erratum in: J Infect Dis. 2003 Oct 1;188(7):1083.

PMID:
12934177
15.

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

Erice A, Tierney C, Hirsch M, Caliendo AM, Weinberg A, Kendall MA, Polsky B; AIDS Clinical Trials Group Protocol 360 Study Team.

Clin Infect Dis. 2003 Aug 15;37(4):567-78. Epub 2003 Jul 29.

PMID:
12905142
16.

Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors.

Henry K, Erice A, Balfour HH Jr, Schmeling M, Berthiaume J, Wallace K.

AIDS. 2002 Dec 6;16(18):2485-7. No abstract available.

PMID:
12461427
17.

Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2.

Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM.

AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):661-5.

PMID:
12079562
18.

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

Demeter LM, Bosch RJ, Coombs RW, Fiscus S, Bremer J, Johnson VA, Erice A, Jackson JB, Spector SA, Squires KM, Fischl MA, Hughes MD, Hammer SM.

J Clin Microbiol. 2002 Jun;40(6):2089-94.

19.

HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.

Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC; Studies of Ocular Complications of AIDS Research Group.

AIDS. 2002 Apr 12;16(6):877-87.

PMID:
11919489
20.

[GESIDA Consensus document on the use of resistance studies in clinical practice].

Gatell JM, Blanco JL, Alcamí J, Antela A, Arrizabalaga J, Casado JL, Clotet B, Delgado R, Erice A, Guerra L, Guerrero A, Iribarren JA, Leal M, López JC, Menéndez-Arias L, Miró JM, Moreno S, Pérez JL, Pumarola T, Rubio R, Ruiz L, Santamaría JM, Soriano V, Telenti A, Viciana P.

Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):53-60. Review. Spanish. No abstract available.

PMID:
11428062
21.

[Comparative analysis of methods for detecting resistance].

Erice A, Pérez JL, Pumarola T.

Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):14-21. Spanish. No abstract available.

PMID:
11428053
22.

Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals.

Erice A, Li W, Balfour HH Jr, Boies LR Jr, Melroe H, Henry K.

AIDS. 2001 May 4;15(7):831-6.

PMID:
11399955
23.

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R, Crumpacker C, Lurain NS, Erice A; CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group.

J Clin Microbiol. 2001 Apr;39(4):1334-8.

24.

Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.

Erice A, Brambilla D, Bremer J, Jackson JB, Kokka R, Yen-Lieberman B, Coombs RW.

J Clin Microbiol. 2000 Aug;38(8):2837-45.

25.

Viability and functional activity of cryopreserved mononuclear cells.

Weinberg A, Zhang L, Brown D, Erice A, Polsky B, Hirsch MS, Owens S, Lamb K.

Clin Diagn Lab Immunol. 2000 Jul;7(4):714-6.

26.

CMV antigenemia following bone marrow transplantation: risk factors and outcomes.

Osarogiagbon RU, Defor TE, Weisdorf MA, Erice A, Weisdorf DJ.

Biol Blood Marrow Transplant. 2000;6(3):280-8.

27.
28.

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.

Antimicrob Agents Chemother. 2000 Mar;44(3):688-92.

29.
30.
31.

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly WG, Henry K.

AIDS. 1999 Feb 4;13(2):F23-8.

PMID:
10202820
32.

Resistance of human cytomegalovirus to antiviral drugs.

Erice A.

Clin Microbiol Rev. 1999 Apr;12(2):286-97. Review.

33.
34.

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

Henry K, Erice A, Tierney C, Balfour HH Jr, Fischl MA, Kmack A, Liou SH, Kenton A, Hirsch MS, Phair J, Martinez A, Kahn JO.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):339-49.

PMID:
9833742
35.

Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group.

Demeter LM, D'Aquila R, Weislow O, Lorenzo E, Erice A, Fitzgibbon J, Shafer R, Richman D, Howard TM, Zhao Y, Fisher E, Huang D, Mayers D, Sylvester S, Arens M, Sannerud K, Rasheed S, Johnson V, Kuritzkes D, Reichelderfer P, Japour A.

J Virol Methods. 1998 Nov;75(1):93-104.

PMID:
9820578
36.

Concentration-controlled zidovudine therapy.

Fletcher CV, Acosta EP, Henry K, Page LM, Gross CR, Kawle SP, Remmel RP, Erice A, Balfour HH Jr.

Clin Pharmacol Ther. 1998 Sep;64(3):331-8.

PMID:
9757157
37.
38.

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.

Gaudreau A, Hill E, Balfour HH Jr, Erice A, Boivin G.

J Infect Dis. 1998 Aug;178(2):297-303.

PMID:
9697707
39.

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.

Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT.

Ann Intern Med. 1997 Jun 15;126(12):929-38.

PMID:
9182469
40.

Pharmacokinetics and safety of concentration-controlled oral zidovudine therapy.

Acosta EP, Henry K, Page LM, Erice A, Balfour HH Jr, Fletcher CV.

Pharmacotherapy. 1997 May-Jun;17(3):424-30.

PMID:
9165546
41.

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.

Erice A, Gil-Roda C, Pérez JL, Balfour HH Jr, Sannerud KJ, Hanson MN, Boivin G, Chou S.

J Infect Dis. 1997 May;175(5):1087-92.

PMID:
9129070
42.
43.

Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

Balfour HH Jr, Fletcher CV, Erice A, Henry WK, Acosta EP, Smith SA, Holm MA, Boivin G, Shepp DH, Crumpacker CS, Eaton CA, Martin-Munley SS.

Antimicrob Agents Chemother. 1996 Dec;40(12):2721-6.

44.

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, Dailey PJ, Balfour HH Jr, Erice A, Perelson AS.

Science. 1996 Nov 8;274(5289):985-9.

PMID:
8875941
45.

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):235-46.

PMID:
8898668
46.

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.

Shafer RW, Winters MA, Mayers DL, Japour AJ, Kuritzkes DR, Weislow OS, White F, Erice A, Sannerud KJ, Iversen A, Pena F, Dimitrov D, Frenkel LM, Reichelderfer PS.

J Clin Microbiol. 1996 Jul;34(7):1849-53.

47.

Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers.

Faust RA, Henry K, Dailey P, Melroe H, Sullivan C, Erice A, Haase AT, Boies LR Jr.

Otolaryngol Head Neck Surg. 1996 Apr;114(4):593-8.

PMID:
8643270
48.
49.

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir.

Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A.

Antimicrob Agents Chemother. 1995 May;39(5):1204-5.

50.

Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions.

Erice A, Holm MA, Sanjuan MV, Dunn DL, Gill PC, Balfour HH Jr.

J Clin Microbiol. 1995 Apr;33(4):1014-5.

Supplemental Content

Support Center